AI and Biotech Sales Jobs: What’s Actually Changing

The information edge is mostly gone. SRC looks at how AI shifts competitive advantage differently across catalogue products, specialised kits, and capital equipment — and what it means for commercial hiring in life sciences. What AI Is Actually Doing to Biotech Sales Jobs Last year, O2 — the UK mobile carrier — built an AI […]

California vs Massachusetts: Who Really Pays More in -Omics Commercial Roles?

Most salary surveys give you a national median and call it a market. This one doesn’t. We looked at 334 individual data points from field commercial roles in the -omics capex, reagents, and distributor segment — and found that neither state wins outright. The answer shifts with career stage, and each shift has a different […]

Paid Less, Performing More: The Gender Pay Gap in Biotech -Omics Sales

Key Findings — SRC-Search EMEA Data 2026 Each month, SRC-Search analyses salary and representation data across commercial careers in the -omics space. Last month we explored how salaries vary across Europe. This month, we turn to something our data has consistently revealed: a persistent — and in many ways counterintuitive — gender gap in pay […]

Biotech Sales & Support Salaries in Europe: 2025 Benchmark Across UK, DACH, France & Benelux

2025 European biotech commercial salary insights - SRC-Search

This benchmark analyses base salary ranges for commercial sales and field support roles across European biotech and -omics companies, based on 956 data points collected from professionals in the UK, Germany, Switzerland, France, Benelux, and Nordic markets in 2025. Key Findings Introduction How do most companies benchmark commercial salaries? They buy a compensation survey. Often, […]

The 2025 Omics Capital Equipment Commercial Overview: What Happened and What’s Next

Omics capital equipment commercial market overview 2025 — infographic

In 2025, the omics capital equipment market exceeded $60 billion in value but experienced significant commercial disruption. Geopolitical pressures, reduced NIH funding, and an AI-driven shift in investor focus led to widespread layoffs at companies including Illumina, PacBio, Oxford Nanopore, and 10x Genomics. Commercial roles in marketing, business development, and non-revenue FAS positions were most […]